Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Reported Tuberculosis in the United States, 2009

Preface

(PDF – 452k)

Reported Tuberculosis in the United States, 2009 presents summary data for tuberculosis (TB) cases verified and counted in 2009. Reports of verified cases of tuberculosis (RVCT) are submitted to the Division of Tuberculosis Elimination (DTBE), Centers for Disease Control and Prevention (CDC) by 60 reporting areas (the 50 states, the District of Columbia, New York City, Puerto Rico, and seven other jurisdictions in the Pacific and Caribbean). First released in 1993, the RVCT was expanded in 2009 to collect additional information for each reported TB case in order to better monitor trends in TB and TB control.

Reported Tuberculosis in the United States, 2009 is similar to previous publications (see page xi, #19) and contains an Executive Commentary, Technical Notes, and six major sections. The Executive Commentary includes highlights of the 2009 data, and Technical Notes provides information about how the data were collected and reported; these sections are included to help the reader interpret the data.

Morbidity Trend Tables, United States, presents trends in the overall TB case counts and case rates by selected demographic and clinical characteristics. Morbidity Tables, United States, 2009, presents overall case counts and case rates for the United States by selected demographic characteristics. Morbidity Tables, Reporting Areas, United States, 2009, presents TB case counts and case rates by state and other jurisdictions with tables of selected demographic and clinical characteristics. Morbidity Tables, Reporting Areas, United States, 2009 and 2007, presents the most recent year for which data are available on selected variables, such as completion of therapy, by reporting area. Morbidity Tables, Cities and Metropolitan Statistical Areas, 2009, provides TB case counts and case rates by metropolitan statistical areas (MSAs: see Technical Notes, page 9, for further details) with tables of selected demographic and clinical characteristics. Surveillance Slide Set, 2009, presents figures from the annual surveillance slide set, which emphasize key recent trends in TB epidemiology in the United States. The slides with accompanying text can also be viewed and downloaded from the DTBE website, which is accessible via the Internet at http://www.cdc.gov/tb/.

The current Tuberculosis Case Definition for Public Health Surveillance and Recommendations for Reporting and Counting Tuberculosis Cases are provided in Appendices A and B, respectively (page 121).

National Surveillance for Severe Adverse Events Associated with Treatment for Latent Tuberculosis Infection - Reporting Information

This information is included to alert our public health partners of the importance of reporting severe adverse events (i.e., hospitalization or death) associated with treatment for latent TB infection (LTBI). Data on severe adverse events (SAEs) among persons receiving treatment for LTBI are needed to assist in the prevention of SAEs and to serve as a basis for periodic evaluation of guidelines for treatment of LTBI.

In April 2000, after the publication of updated Guidelines for Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection1, DTBE began receiving reports of SAEs related to the use of a 2-month course of rifampin and pyrazinamide (RZ) for treatment of LTBI. In response, DTBE requested and received reports and conducted on-site investigations of liver injury in persons on treatment for LTBI, and treatment guidelines were revised accordingly.2, 3 In January 2004, DTBE implemented the National Surveillance System for Severe Adverse Events Associated with Treatment for LTBI to quantify the frequency of SAEs and to characterize the clinical features of affected patients. A summary report from this surveillance system has recently been published.4

Local medical providers should report possible LTBI-treatment associated SAEs to their respective local/state health departments. State health departments should report SAEs that occurred after January 1, 2004, to DTBE
(e-mail: LTBIdrugevents@cdc.gov).

References

1. ATS/CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.

2. American Thoracic Society/CDC. Update: Adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection—United States, 2003. MMWR 2003;52(31):735-9.

3. ATS. An official ATS statement: hepatoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006;174:935–52.

4. CDC. Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection — United States, 2004–2008. MMWR 2010;59(8):224–9.

Top of Page

Previous Statistical Reports in this Series:

  1. Special Tuberculosis Projects, 1961–1965. Atlanta: CDC; 1966.
  2. Special Tuberculosis Projects, December 1965. Atlanta: CDC; 1966.
  3. Special Tuberculosis Projects, June 1966. Atlanta: CDC; 1967.
  4. Special Tuberculosis Projects, December 1966. Atlanta: CDC; 1967.
  5. Summary Report. Atlanta: CDC; 1967.
  6. Special Tuberculosis Projects, June 1967. Atlanta: CDC; 1968.
  7. Tuberculosis Program Reports, December 1967. Atlanta: CDC; 1968.
  8. Tuberculin testing during 1966–1967 school year. In: Tuberculosis Program Reports. Atlanta: CDC; 1968.
  9. Tuberculosis Program Reports: Six Month Period Ending June 1968. Atlanta: CDC; 1969.
  10. Program Performance Analyses, June–December 1968. In: Tuberculosis Program Reports. Atlanta: CDC; 1970.
  11. Tuberculin testing data, 1967–1968 school year. In: Tuberculosis Program Reports. Atlanta: CDC; 1970.
  12. The project years, 1961–1969, In: Tuberculosis Program Reports. Atlanta: CDC; 1970.
  13. Tuberculosis programs (for years 1970–1973). In: Tuberculosis Program Reports. Atlanta: CDC; 1971–1974.
  14. Reported Tuberculosis Data (for years 1962–1973). Atlanta: CDC; 1963–1974.
  15. Tuberculosis Statistics: States and Cities (for years 1974–1985). Atlanta: CDC; 1971–1986.
  16. Tuberculosis in the United States (for years 1974–1986). Atlanta: CDC; 1976–1987.
  17. Tuberculosis program management in the United States, 1984. In: Tuberculosis Program Reports. Atlanta: CDC; 1986.
  18. Tuberculosis Statistics in the United States (for years 1987–1992). Atlanta: CDC: 1989–1993.
  19. Reported Tuberculosis in the United States (for years 1993–2008). Atlanta: CDC: 1994–2009.

Reports from 2005 through 2009 are available on the Internet at
http://www.cdc.gov/tb/statistics/

Top of Page

State TB Resources on the Internet*

AL http://www.adph.org/tb/
AK http://www.epi.alaska.gov/id/tb.stm
AR http://www.healthy.arkansas.gov/programsServices/infectiousDisease/tuberculosis
AZ http://www.azdhs.gov/phs/oids/tuberculosis
CA http://ww2.cdph.ca.gov/programs/tb/Pages/default.aspx
CO http://www.cdphe.state.co.us/dc/tb/tbhome.html
CT http://www.ct.gov/dph/cwp/view.asp?a=3136&q=388584&dphNav_GID=1601&dphPNavCtr=|#47055
DC http://doh.dc.gov/doh/cwp/view,a,1374,q,580737.asp
DE http://dhss.delaware.gov/dph/dpc/tbelimination.html
FL http://www.doh.state.fl.us/disease_ctrl/tb/
GA http://health.state.ga.us/epi/tuber.asp
HI http://hawaii.gov/health/family-child-health/contagious-disease/tb/index.html
IA http://www.idph.state.ia.us/adper/tb_control.asp
ID http://www.healthandwelfare.idaho.gov/Health/DiseasesConditions/Tuberculosis/tabid/378/Default.aspx
IL http://www.idph.state.il.us/health/infect/reportdis/tb.htm
IN http://www.in.gov/isdh/19662.htm
KS http://www.kdheks.gov/tb/statistical_information.html
KY http://chfs.ky.gov/dph/epi/tb.htm
LA http://www.dhh.louisiana.gov/offices/?ID=273
MA http://www.mass.gov/dph/cdc/tb
MD http://www.edcp.org/tb/index.cfm
ME http://www.maine.gov/dhhs/boh/ddc/epi/tuberculosis/
MI http://www.michigan.gov/tb
MN http://www.health.state.mn.us/divs/idepc/diseases/tb/stats.html
MO http://www.dhss.mo.gov/Tuberculosis/Data.html
MT http://www.dphhs.mt.gov/PHSD/epidemiology/commun-disease-epi-tuberculosis.shtml
MS http://www.msdh.state.ms.us/msdhsite/_static/14,0,125.html
ND http://www.ndhealth.gov/disease/tb/
NC http://www.epi.state.nc.us/epi/tb
NE http://www.dhhs.ne.gov/cod/Tuberculosis/tbindex.htm
NH http://www.dhhs.state.nh.us/DHHS/CDCS/tbinfo.htm
NJ http://www.state.nj.us/health/cd/tbhome.htm
NM http://nmhealth.org/ERD/HealthData/tb_data.shtml
NYC http://www.nyc.gov/html/doh/html/tb/tb-reports.shtml
NV http://www.health.nv.gov/CD_HIV_TBProgram.htm
NY http://www.nyhealth.gov/statistics/diseases/communicable/tuberculosis/
OH http://www.odh.ohio.gov/healthstats/disease/tb/tb1.aspx
OK http://www.ok.gov/health/Disease,_Prevention,_Preparedness/Acute_Disease_Service/Disease_Information/ Tuberculosis.html
OR http://oregon.gov/DHS/ph/tb/
PA http://www.health.state.pa.us/PHP/TB/tb.htm
RI http://www.health.ri.gov/disease/communicable/tb/index.php
PR http://www.salud.gov.pr/Programas/ProgramaTuberculosis/ Pages/DatosEstadisticosTuberculosis.aspx
SC http://www.scdhec.net/health/disease/tb/index.htm
SD http://doh.sd.gov/tb
TN http://health.state.tn.us/CEDS/TB/index.htm
TX http://www.dshs.state.tx.us/idcu/disease/tb/statistics/
UT http://www.health.utah.gov/cdc/tb_home.htm
VA http://www.vdh.virginia.gov/epidemiology/DiseasePrevention/Programs/Tuberculosis/Epidemiology/
VT http://healthvermont.gov/prevent/tb/Tuberculosis.aspx
WA http://www.doh.wa.gov/cfh/tb
WI http://www.dhs.wisconsin.gov/tb/
WV http://www.wvtb.org
WY http://www.health.wyo.gov/PHSD/tb

*As reported to CDC by U.S. reporting area TB programs as of July 2010. Includes responses from the reporting areas of New York City (NYC) and Puerto Rico (PR).

Top of Page

 

Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #